2013Chinese Journal of Birth Health & HeredityRequires access

Application of Cystatin C,microalbuminuria in patients who had hypertensive disorder complicating pregnancy with early renal impairment

Lai Jing-yu

Open publisher page 0 citations

Abstract

Objective: This study evaluated serum Cystatin C,microalbuminuria as a potential new marker of glomerular fihration rate(GFR) in patients who had hypertensive disorder complicating pregnancy(HDCP) with early renal impairment.To study the early diagnostic value of serum Cystain C,mAlb for the patients with HDCP.Methods: The serum Cys-C,mAlb and Scr,BUN level were measured and comparatived in 40 patients who had HDCP with early renal impairments and 40 health controls patients.Results: The results of the patients with HDCP are Cys-C(1.41 ± 0.39).BUN(4.20 ± 1.01).Cr(61.8 ± 6.62) and mAlb(29.2 ± 7.82),the results of health controls are Cys-C(0.82 ± 0.21).BUN(4.12 ± 0.98).Cr(60.3 ± 6.85) and mAlb(7.95 ± 3.66).Conclusions: Serum Cystatin C,mAlb is very value for the patients with HDCP,there is very important singificat to check Cystatin C in the patients with HDCP.

About this research paper

What this paper is about

Objective: This study evaluated serum Cystatin C,microalbuminuria as a potential new marker of glomerular fihration rate(GFR) in patients who had hypertensive disorder complicating pregnancy(HDCP) with early renal impairment.To study the early diagnostic value of serum Cystain C,mAlb for the patients with HDCP.Methods: The serum Cys-C,mAlb and Scr,BUN level were measured and comparatived in 40 patients who had HDCP with early renal impairments and 40 health controls patients.Results: The results of the patients with HDCP are Cys-C(1.41 ± 0.39).BUN(4.20 ± 1.01).Cr(61.8 ± 6.62) and mAlb(29.2 ± 7.82),the results of health controls are Cys-C(0.82 ± 0.21).BUN(4.12 ± 0.98).Cr(60.3 ± 6.85) and mAlb(7.95 ± 3.66).Conclusions: Serum Cystatin C,mAlb is very value for the patients with HDCP,there is very important singificat to check Cystatin C in the patients with HDCP.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: This study evaluated serum Cystatin C,microalbuminuria as a potential new marker of glomerular fihration rate(GFR) in patients who had hypertensive disorder complicating pregnancy(HDCP) with early renal impairment.To study the early diagnostic value of serum Cystain C,mAlb for the patients with HDCP.Methods: The serum Cys-C,mAlb and Scr,BUN level were measured and comparatived in 40 patients who had HDCP with early renal impairments and 40 health controls patients.Results: The results of the patients with HDCP are Cys-C(1.41 ± 0.39).BUN(4.20 ± 1.01).Cr(61.8 ± 6.62) and mAlb(29.2 ± 7.82),the results of health controls are Cys-C(0.82 ± 0.21).BUN(4.12 ± 0.98).Cr(60.3 ± 6.85) and mAlb(7.95 ± 3.66).Conclusions: Serum Cystatin C,mAlb is very value for the patients with HDCP,there is very important singificat to check Cystatin C in the patients with HDCP.

Key concepts: Cystatin C, Microalbuminuria, Medicine, Internal medicine, Renal function, Cystatin, Gastroenterology, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Application of Cystatin C,microalbuminuria in patients who had hypertensive disorder complicating pregnancy with early renal impairment — Research Paper | ScholarLens